Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Julio Pascual & Carlos Vila. (2019) Almotriptan: a review of 20 years’ clinical experience. Expert Review of Neurotherapeutics 19:8, pages 759-768.
Read now
Read now
Paolo Martelletti. (2017) Acute treatment of migraine: quo vadis?. Expert Opinion on Pharmacotherapy 18:11, pages 1035-1037.
Read now
Read now
Matilde Capi, Fernando de Andrés, Luana Lionetto, Giovanna Gentile, Fabiola Cipolla, Andrea Negro, Marina Borro, Paolo Martelletti & Martina Curto. (2017) Lasmiditan for the treatment of migraine. Expert Opinion on Investigational Drugs 26:2, pages 227-234.
Read now
Read now
Peiwei Hong & Yao Liu. (2017) Calcitonin gene-related peptide antagonism for acute treatment of migraine: a meta-analysis. International Journal of Neuroscience 127:1, pages 20-27.
Read now
Read now
Anna Ferrari, Carlo Baraldi & Emilio Sternieri. (2015) Medication overuse and chronic migraine: a critical review according to clinical pharmacology. Expert Opinion on Drug Metabolism & Toxicology 11:7, pages 1127-1144.
Read now
Read now
Articles from other publishers (23)
Laura Pilati, Angelo Torrente, Salvatore Di Marco, Salvatore Ferlisi, Giulia Notaro, Marika Romano, Paolo Alonge, Lavinia Vassallo, Ludovica Ferraù, Massimo Autunno, Rosario Grugno, Cecilia Camarda & Filippo Brighina. (2023) Erenumab and Possible CGRP Effect on Chronotype in Chronic Migraine: A Real-Life Study of 12 Months Treatment. Journal of Clinical Medicine 12:10, pages 3585.
Crossref
Crossref
Michele Trimboli, Oreste Marsico, Letizia Troisi & Francesco Fasano. (2023) External trigeminal neurostimulation in patients with chronic migraine. Pain Management.
Crossref
Crossref
Andrew Blumenfeld, Aud Nome Dueland, Stefan Evers, Bronwyn Jenkins, Paolo Martelletti & Katherine Sommer. (2022) Practical Insights on the Identification and Management of Patients with Chronic Migraine. Pain and Therapy 11:2, pages 447-457.
Crossref
Crossref
Eleonora De Matteis, Giannapia Affaitati, Ilaria Frattale, Valeria Caponnetto, Francesca Pistoia, Maria Adele Giamberardino, Simona Sacco & Raffaele Ornello. (2021) Early outcomes of migraine after erenumab discontinuation: data from a real-life setting. Neurological Sciences 42:8, pages 3297-3303.
Crossref
Crossref
Eleonora De Matteis, Raffaele Ornello & Simona Sacco. 2021. Monoclonal Antibodies in Headache. Monoclonal Antibodies in Headache
151
166
.
Raffaele Ornello, Alfonsina Casalena, Ilaria Frattale, Amleto Gabriele, Giannapia Affaitati, Maria Adele Giamberardino, Maurizio Assetta, Maurizio Maddestra, Fabio Marzoli, Stefano Viola, Davide Cerone, Carmine Marini, Francesca Pistoia & Simona Sacco. (2020) Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy. The Journal of Headache and Pain 21:1.
Crossref
Crossref
Damiana Scuteri, Annagrazia Adornetto, Laura Rombolà, MariaDiana Naturale, AdeleEmanuela De Francesco, Stefania Esposito, Mariacristina Zito, LuigiAntonio Morrone, Giacinto Bagetta, Paolo Tonin & MariaTiziana Corasaniti. (2020) Pattern of triptans use: a retrospective prescription study in Calabria, Italy. Neural Regeneration Research 15:7, pages 1340.
Crossref
Crossref
Damiana Scuteri, Annagrazia Adornetto, Laura Rombolà, MariaDiana Naturale, AdeleEmanuela De Francesco, Stefania Esposito, Mariacristina Zito, LuigiAntonio Morrone, Giacinto Bagetta, Paolo Tonin & MariaTiziana Corasaniti. (2020) Pattern of triptans use: a retrospective prescription study in Calabria, Italy. Neural Regeneration Research 15:3, pages 1340.
Crossref
Crossref
Fang Xu & Wenjun Sun. (2019) Network Meta-Analysis of Calcitonin Gene-Related Peptide Receptor Antagonists for the Acute Treatment of Migraine. Frontiers in Pharmacology 10.
Crossref
Crossref
Marco Annoni & Franklin G. Miller. 2019. Placebos and Nocebos in Headaches. Placebos and Nocebos in Headaches
135
142
.
Karissa E. Cottier, Emily A. Galloway, Elisa C. Calabrese, Margaret E. Tome, Erika Liktor-Busa, John Kim, Thomas P. Davis, Todd W. Vanderah & Tally M. Largent-Milnes. (2018) Loss of Blood-Brain Barrier Integrity in a KCl-Induced Model of Episodic Headache Enhances CNS Drug Delivery. eneuro 5:4, pages ENEURO.0116-18.2018.
Crossref
Crossref
Richard B. Lipton, Sagar Munjal, Elimor Brand‐Schieber & Alan M. Rapoport. (2018) DFN‐02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double‐Blind, Placebo‐Controlled Study. Headache: The Journal of Head and Face Pain 58:5, pages 676-687.
Crossref
Crossref
Jan de Hoon, Anne Van Hecken, Corinne Vandermeulen, Lucy Yan, Brian Smith, Jiyun Sunny Chen, Edgar Bautista, Lisa Hamilton, Javier Waksman, Thuy Vu & Gabriel Vargas. (2017) Phase I, Randomized, Double‐blind, Placebo‐controlled, Single‐dose, and Multiple‐dose Studies of Erenumab in Healthy Subjects and Patients With Migraine. Clinical Pharmacology & Therapeutics 103:5, pages 815-825.
Crossref
Crossref
Alexander J. Sandweiss, Karissa E. Cottier, Mary I. McIntosh, Gregory Dussor, Thomas P. Davis, Todd W. Vanderah & Tally M. Largent-Milnes. (2017) 17-β-Estradiol induces spreading depression and pain behavior in alert female rats. Oncotarget 8:69, pages 114109-114122.
Crossref
Crossref
Sagar Munjal, Elimor Brand-Schieber, Kent Allenby, Egilius L.H. Spierings, Roger K. Cady & Alan M. Rapoport. (2017) A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of episodic migraine. The Journal of Headache and Pain 18:1.
Crossref
Crossref
Lanfranco Pellesi, Simona Guerzoni & Luigi Alberto Pini. (2017) Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date. Clinical Pharmacology in Drug Development 6:6, pages 534-547.
Crossref
Crossref
Giannapia Affaitati, Paolo Martelletti, Mariangela Lopopolo, Claudio Tana, Francesca Massimini, Francesco Cipollone, Domenico Lapenna, Maria Adele Giamberardino & Raffaele Costantini. (2017) Use of Nonsteroidal Anti-Inflammatory Drugs for Symptomatic Treatment of Episodic Headache. Pain Practice 17:3, pages 392-401.
Crossref
Crossref
Ju-Fen Yeh, Aysen Akinci, Mohammed Al Shaker, Ming Hong Chang, Andrei Danilov, Rocio Guillen, Kirk W Johnson, Yong-Chul Kim, Ahmed A El-Shafei, Vladimir Skljarevski, Héctor J Dueñas & Warat Tassanawipas. (2017) Monoclonal antibodies for chronic pain: A practical review of mechanisms and clinical applications. Molecular Pain 13, pages 174480691774023.
Crossref
Crossref
Fabio Antonaci, Natascia Ghiotto, Shizheng Wu, Ennio Pucci & Alfredo Costa. (2016) Recent advances in migraine therapy. SpringerPlus 5:1.
Crossref
Crossref
Maria Adele Giamberardino, Giannapia Affaitati, Paolo Martelletti, Claudio Tana, Andrea Negro, Domenico Lapenna, Martina Curto, Cosima Schiavone, Luisa Stellin, Francesco Cipollone & Raffaele Costantini. (2016) Impact of migraine on fibromyalgia symptoms. The Journal of Headache and Pain 17:1.
Crossref
Crossref
Maria Adele Giamberardino, Giannapia Affaitati, Martina Curto, Andrea Negro, Raffaele Costantini & Paolo Martelletti. (2016) Anti-CGRP monoclonal antibodies in migraine: current perspectives. Internal and Emergency Medicine 11:8, pages 1045-1057.
Crossref
Crossref
Maria Adele Giamberardino, Dimos-Dimitrios Mitsikostas & Paolo Martelletti. (2015) Update on Medication-Overuse Headache and Its Treatment. Current Treatment Options in Neurology 17:8.
Crossref
Crossref
Stephanie Wrobel Goldberg & Stephen David Silberstein. (2015) Targeting CGRP: A New Era for Migraine Treatment. CNS Drugs 29:6, pages 443-452.
Crossref
Crossref